The psychology of LUTS: ICI-RS 2011

Neurourology and Urodynamics

Volumn 31, Issue 3, 2012, Pages 340-343

  Cortes, E ^a   Sahai, A ^b   Pontari, M ^c   Kelleher, C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

childhood enuresis; LUTS; psychology; somatoform disorders

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DULOXETINE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR;

ALLODYNIA; ANXIETY DISORDER; BLADDER DISTENSION; BLADDER DYSFUNCTION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; EMOTIONAL STRESS; ENVIRONMENTAL FACTOR; FIBROMYALGIA; HEREDITY; HUMAN; INTERSTITIAL CYSTITIS; IRRITABLE COLON; LOWER URINARY TRACT SYMPTOM; MENTAL HEALTH; MENTAL STRESS; MICTURITION; MORBIDITY; NEUROPSYCHOLOGY; NOCTURNAL ENURESIS; NONHUMAN; PANIC; PELVIS PAIN SYNDROME; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; REVIEW; SOMATOFORM DISORDER; TENSION HEADACHE; URINARY FREQUENCY; URINE INCONTINENCE;

AGE FACTORS; ANIMALS; CYSTITIS, INTERSTITIAL; EMOTIONS; EVIDENCE-BASED MEDICINE; HUMANS; LOWER URINARY TRACT SYMPTOMS; NOCTURNAL ENURESIS; RISK ASSESSMENT; RISK FACTORS; SOMATOFORM DISORDERS; STRESS, PSYCHOLOGICAL; URINARY BLADDER; URINATION; URODYNAMICS;

EID: 84859110700     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22211     Document Type: Review

References (43)

1. Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: Results from the epidemiology of LUTS (EpiLUTS) study. BJU Int 2009; 104: 352-60;.
2. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006; 50: 1306-14;, discussion 14-5.
3. Coyne KS, Wein AJ, Tubaro A, et al. The burden of lower urinary tract symptoms: Evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 2009; 103: 4-11;.
4. Coyne KS, Kvasz M, Ireland AM, et al. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol 2012; 61: 88-95;.
5. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: Results from the EPIC study. BJU Int 2008; 101: 1388-95;.
6. Coyne KS, Sexton CC, Kopp ZS, et al. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: Results from EpiLUTS. BJU Int 2011; 108: 1459-71;.
7. American Psychiatric Association APATFoD-I. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Arlington, VA: American Psychiatric Publishing; 2000.
8. Stone J, Carson A, Sharpe M,. Functional symptoms in neurology: Management. J Neurol Neurosurg Psychiatry 2005; 76: i13-21;.
9. Butler RJ, Golding J, Northstone K,. Nocturnal enuresis at 7.5 years old: Prevalence and analysis of clinical signs. BJU Int 2005; 96: 404-10;.
10. Mammen AA, Ferrer FA,. Nocturnal enuresis: Medical management. Urol Clin North Am 2004; 31: 491-8;, ix.
11. von Gontard A, Schaumburg H, Hollmann E, et al. The genetics of enuresis: A review. J Urol 2001; 166: 2438-43;.
12. Sureshkumar P, Jones M, Caldwell PH, et al. Risk factors for nocturnal enuresis in school-age children. J Urol 2009; 182: 2893-9;.
13. Joinson C, Heron J, Butler R, et al. A United Kingdom population-based study of intellectual capacities in children with and without soiling, daytime wetting, and bed-wetting. Pediatrics 2007; 120: e308-16;.
14. Franco I,. New ideas in the cause of bladder dysfunction in children. Curr Opin Urol 2011; 21: 334-8;.
15. von Gontard A, Baeyens D, Van Hoecke E, et al. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol 2011; 185: 1432-6;.
16. von Gontard A, Heron J, Joinson C,. Family history of nocturnal enuresis and urinary incontinence: Results from a large epidemiological study. J Urol 2011; 185: 2303-6;.
17. Kuhn S, Natale N, Siemer S, et al. Clinical differences in daytime wetting subtypes: Urge incontinence and postponed voiding. J Urol 2009; 182: 1967-72;.
18. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78;.
19. Clemens JQ, Link CL, Eggers PW, et al. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol 2007; 177: 1390-4;.
20. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Case-control study of medical comorbidities in women with interstitial cystitis. J Urol 2008; 179: 2222-5;.
21. Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 2010; 184: 1358-63;.
22. Mayson BE, Teichman JM,. The relationship between sexual abuse and interstitial cystitis/painful bladder syndrome. Curr Urol Rep 2009; 10: 441-7;.
23. Clemens JQ, Brown SO, Calhoun EA,. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: A case/control study. J Urol 2008; 180: 1378-82;.
24. Weissman MM, Gross R, Fyer A, et al. Interstitial cystitis and panic disorder: A potential genetic syndrome. Arch Gen Psychiatry 2004; 61: 273-9;.
25. Wright LJ, Noonan C, Ahumada S, et al. Psychological distress in twins with urological symptoms. Gen Hosp Psychiatry 2010; 32: 262-7;.
26. Chang HY, Cheng CL, Chen JJ, et al. Roles of glutamatergic and serotonergic mechanisms in reflex control of the external urethral sphincter in urethane-anesthetized female rats. Am J Physiol Regul Integr Comp Physiol 2006; 291: R224-34;.
27. Klausner AP, Steers WD,. Corticotropin releasing factor: A mediator of emotional influences on bladder function. J Urol 2004; 172: 2570-3;.
28. Kiddoo DA, Valentino RJ, Zderic S, et al. Impact of state of arousal and stress neuropeptides on urodynamic function in freely moving rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1697-706;.
29. Robbins MT, DeBerry J, Ness TJ,. Chronic psychological stress enhances nociceptive processing in the urinary bladder in high-anxiety rats. Physiol Behav 2007; 91: 544-50;.
30. Kirby M, Thor KB,. Is duloxetine safe and effective for the treatment of overactive bladder ? Nat Clin Pract Urol 2008; 5: 188-9;.
31. Votolato NA, Stern S, Caputo RM,. Serotonergic antidepressants and urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 386-8;.
32. Chang HY, Cheng CL, Chen JJ, et al. Serotonergic drugs and spinal cord transections indicate that different spinal circuits are involved in external urethral sphincter activity in rats. Am J Physiol Renal Physiol 2007; 292: F1044-53;.
33. Cheng CL, de Groat WC,. Role of 5-HT1A receptors in control of lower urinary tract function in anesthetized rats. Am J Physiol Renal Physiol 2010; 298: F771-8;.
34. Cardozo L, Lange R, Voss S, et al. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Curr Med Res Opin 2010; 26: 253-61;.
35. Schagen van Leeuwen JH, Lange RR, Jonasson AF, et al. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. Maturitas 2008; 60: 138-47;.
36. Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis 2011 DOI: 10.4061/2011/924605
37. Yokoyama O, Yoshiyama M, Namiki M, et al. Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am J Physiol 1999; 276: R935-42;.
38. Yoshimura N, Kuno S, Chancellor MB, et al. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br J Pharmacol 2003; 139: 1425-32;.
39. Rodrigues AJ, Leao P, Carvalho M, et al. Potential programming of dopaminergic circuits by early life stress. Psychopharmacology (Berl) 2011; 214: 107-20;.
40. Kuramochi M, Nakamura S,. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats. Neuroscience 2009; 163: 448-55;.
41. Pruessner JC, Champagne F, Meaney MJ, et al. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: A positron emission tomography study using [11C]raclopride. J Neurosci 2004; 24: 2825-31;.
42. Holstege G, Mouton LJ, Gerrits NM,. The emotional motor system. In:, Paxinos G, Mai JK, editors. The human nervous system, 2nd edition. Amsterdam: Elsevier; 2004. 1306-24;.
43. Holstege G,. The emotional motor system and micturition control. Neurourol Urodyn 2010; 29: 42-8;.